Shanghai OPM Biosciences Co., Ltd. (SHA:688293)
China
· Delayed Price · Currency is CNY 41.43
-0.57 (-1.36%)
At close: Apr 30, 2025, 2:57 PM CST
Shanghai OPM Biosciences Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Net Income | 21.05 | 54.04 | 105.37 | 60.39 | 11.68 | Upgrade
|
| Depreciation & Amortization | 45.68 | 36.83 | 33.85 | 28.19 | 15.49 | Upgrade
|
| Other Amortization | 12.39 | 5.88 | 5.17 | 4.07 | 2.81 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.09 | - | -0.29 | - | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 7.51 | 0.02 | 0 | 0.02 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -18.25 | -14.59 | -5.81 | -4.18 | -1.44 | Upgrade
|
| Provision & Write-off of Bad Debts | 6.92 | 6.42 | 4.76 | 0.31 | 0.1 | Upgrade
|
| Other Operating Activities | -0.6 | 1.99 | 3.01 | 5.11 | 3.1 | Upgrade
|
| Change in Accounts Receivable | -39.23 | -24.83 | -46.04 | -6.3 | -34.1 | Upgrade
|
| Change in Inventory | -9.41 | -5.62 | -10.56 | -21.26 | 3.12 | Upgrade
|
| Change in Accounts Payable | 38.54 | -8.16 | 16.82 | 40.52 | -1.62 | Upgrade
|
| Change in Other Net Operating Assets | 5.5 | 6.87 | 5.79 | 7.87 | 4.08 | Upgrade
|
| Operating Cash Flow | 69.25 | 57.95 | 111.62 | 114.63 | 3.2 | Upgrade
|
| Operating Cash Flow Growth | 19.49% | -48.08% | -2.62% | 3478.75% | -81.43% | Upgrade
|
| Capital Expenditures | -120.86 | -77.55 | -146.96 | -105.98 | -36.24 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 6.78 | - | - | Upgrade
|
| Cash Acquisitions | - | 0.02 | - | - | - | Upgrade
|
| Investment in Securities | -253.73 | -73.26 | -283.28 | -38 | - | Upgrade
|
| Other Investing Activities | 4.05 | 1.25 | 37.87 | 3.99 | -68.64 | Upgrade
|
| Investing Cash Flow | -370.54 | -149.53 | -385.59 | -139.99 | -104.88 | Upgrade
|
| Long-Term Debt Issued | - | - | 32.34 | 42.82 | 15 | Upgrade
|
| Long-Term Debt Repaid | -11.3 | -45.42 | -62.79 | -21.6 | -23.5 | Upgrade
|
| Net Debt Issued (Repaid) | -11.3 | -45.42 | -30.45 | 21.22 | -8.5 | Upgrade
|
| Issuance of Common Stock | - | - | 1,523 | - | 399.79 | Upgrade
|
| Repurchase of Common Stock | -37.25 | -13.75 | - | - | - | Upgrade
|
| Common Dividends Paid | -51.22 | -73.83 | -2.08 | -1.8 | -2.14 | Upgrade
|
| Other Financing Activities | 0.13 | - | -15.74 | 0.2 | -4.27 | Upgrade
|
| Financing Cash Flow | -99.64 | -133.01 | 1,474 | 19.62 | 384.88 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.42 | 0.95 | 2.35 | -0.24 | -0.53 | Upgrade
|
| Net Cash Flow | -398.51 | -223.64 | 1,203 | -5.99 | 282.67 | Upgrade
|
| Free Cash Flow | -51.61 | -19.59 | -35.34 | 8.64 | -33.04 | Upgrade
|
| Free Cash Flow Margin | -17.36% | -8.06% | -12.01% | 4.06% | -26.44% | Upgrade
|
| Free Cash Flow Per Share | -0.44 | -0.17 | -0.35 | 0.10 | -0.38 | Upgrade
|
| Cash Income Tax Paid | 29.9 | 11.38 | 28.47 | 13.42 | -1.1 | Upgrade
|
| Levered Free Cash Flow | -48.83 | -38.18 | -100.94 | -34.34 | -42.19 | Upgrade
|
| Unlevered Free Cash Flow | -46.88 | -36.16 | -97.83 | -31.35 | -40.66 | Upgrade
|
| Change in Net Working Capital | -6.37 | 20.09 | 51.3 | 0.25 | 30.85 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.